Dimpled Skin (Eczema): A Complete Guide

What is Dimpled skin (eczema)?

Dimpled skin, often described as “pitted” or “crater‑like” lesions, is a common manifestation of eczema (atopic dermatitis) and other inflammatory skin conditions. The term refers to small, shallow depressions that may appear within a red, scaly, or itchy patch. In eczema, these dimples usually develop after the skin has been scratched or rubbed repeatedly, causing the epidermis to become thin and “pinched” by underlying inflammation. The appearance can range from a few isolated pits to widespread “lichenified” (thickened) areas with a characteristic “pebble‑like” texture. While the presence of dimpling does not automatically mean a serious disease, it signifies that the skin barrier is compromised and warrants proper care.

According to the Mayo Clinic, eczema is a chronic, relapsing condition driven by genetics, immune dysregulation, and environmental triggers. Dimpled skin is simply one visual clue that the disease is active.

Common Causes

Several underlying conditions or triggers can lead to dimpled‑type eczema. The most frequent are:

• Atopic dermatitis (classic eczema) – the most common cause; chronic scratching produces the dimpled texture.
• Contact dermatitis – irritation from soaps, detergents, metals, or plants can cause localized eczema with pitting.
• Dyshidrotic eczema – vesicles on the hands/feet that burst, leaving pitted, cracked skin.
• Seborrheic dermatitis – especially on the scalp or face; chronic inflammation can create a “rough” surface.
• Stasis dermatitis – venous insufficiency in the lower legs, leading to swelling, itching, and pitted lesions.
• Ichthyosis vulgaris – inherited scaling that predisposes the skin to fissuring and dimpling.
• Psoriasis – plaques can become lichenified and dimpled after prolonged scratching.
• Scabies – intense itching from the mite leads to secondary eczema with pitting.
• Fungal infections (tinea) – chronic inflammation may mimic or coexist with eczema.
• Genetic skin barrier defects (e.g., filaggrin gene mutations) – impair the skin’s ability to retain moisture, making dimpled eczema more likely.

Associated Symptoms

When dimpled skin appears, other signs often accompany it, helping clinicians narrow the diagnosis:

• Intense itching (pruritus) that worsens at night.
• Redness (erythema) and warmth in the affected area.
• Dry, flaky or scaly patches.
• Thickened, leathery skin (lichenification) from chronic rubbing.
• Weeping or ooze from cracked lesions.
• Skin discoloration (hyper‑ or hypopigmentation) after healing.
• Secondary bacterial infection (e.g., Staphylococcus aureus) causing honey‑colored crusts or pus.
• Swelling (edema) especially in stasis‑related eczema of the legs.

When to See a Doctor

Most cases of mild eczema can be managed at home, but you should seek professional care if you notice any of the following:

• Symptoms persist or worsen despite over‑the‑counter moisturizers and low‑strength steroids.
• Signs of infection: increased pain, warmth, red streaks, pus, or fever.
• Rapid spreading of lesions or emergence of new patches in unusual locations.
• Severe itching that interferes with sleep or daily activities.
• Bleeding, crusting, or ulceration of the skin.
• Any suspicion that the rash may be due to an allergic reaction, medication side effect, or systemic disease.

Prompt evaluation helps prevent complications such as chronic skin thickening, scarring, or systemic infection.

Diagnosis

Healthcare providers use a stepwise approach to confirm dimpled eczema and rule out mimickers.

Clinical Examination

• Visual inspection of pattern, distribution, and texture of lesions.
• Palpation to assess thickness, warmth, and tenderness.
• Review of personal and family history of atopic diseases (asthma, allergic rhinitis).

Diagnostic Tests (when needed)

• Skin scrapings for microscopy or culture to exclude fungal infection or scabies.
• Patch testing if contact dermatitis is suspected.
• Blood eosinophil count or serum IgE – may be elevated in atopic individuals but not diagnostic.
• Skin biopsy – rarely required; performed if psoriasis, lymphoma, or other atypical conditions are considered.

Assessment Tools

The Eczema Area and Severity Index (EASI) and the Patient‑Oriented Eczema Measure (POEM) are commonly used to gauge disease extent and guide treatment decisions.

Treatment Options

Management combines skin‑care basics, prescription medication, and lifestyle adjustments. Treatment is individualized according to severity, age, and comorbidities.

1. Skin‑Care Basics (Home Treatment)

• Moisturize frequently – apply fragrance‑free emollients (e.g., petrolatum, ceramide‑rich creams) within 3 minutes of bathing.
• Gentle cleansing – use lukewarm water and mild, pH‑balanced soaps or non‑soap cleansers.
• Short, lukewarm baths – add colloidal oatmeal or baking soda to reduce itching.
• Avoid scratching – keep nails trimmed, consider cotton gloves at night.
• Wet‑wrap therapy – for severe flares: apply a topical steroid, then moistened gauze, and cover with a dry layer for 12‑24 h.

2. Topical Medications

• Low‑ to mid‑potency corticosteroids (hydrocortisone 1 %, triamcinolone 0.1 %) – first‑line for mild‑moderate flares.
• High‑potency steroids (clobetasol, betamethasone dipropionate) – short‑term use for thick, lichenified plaques.
• Topical calcineurin inhibitors (tacrolimus ointment, pimecrolimus cream) – steroid‑sparing agents, safe for face and flexural areas.
• Phosphodiesterase‑4 inhibitor (crisaborole 2 % ointment) – non‑steroid option for mild‑moderate disease.

3. Systemic Therapies (moderate‑severe or refractory disease)

• Oral antihistamines – mainly for night‑time itching; non‑sedating options preferred.
• Oral corticosteroids – short courses (< 2 weeks) for acute severe flares; long‑term use discouraged due to side effects.
• Immunomodulators (e.g., cyclosporine, methotrexate, azathioprine) – for chronic, severe eczema under specialist supervision.
• Biologic agents – Dupilumab (IL‑4Rα antagonist) is FDA‑approved for adults and adolescents with moderate‑to‑severe atopic dermatitis; newer agents (e.g., tralokinumab, lebrikizumab) are emerging.

4. Treating Secondary Infection

• Topical antibiotics (mupirocin, fusidic acid) for localized bacterial involvement.
• Oral antibiotics (dicloxacillin, cephalexin) for extensive infection or systemic signs.

5. Adjunctive Therapies

• Phototherapy (narrow‑band UVB) – helpful for widespread disease unresponsive to topicals.
• Probiotics and dietary omega‑3 supplementation – evidence suggests modest benefit in some patients (NIH).

Prevention Tips

While eczema cannot always be prevented, the following strategies lower the risk of flare‑ups and dimpled skin formation:

• Maintain a robust skin barrier – moisturize at least twice daily, especially after bathing.
• Identify and avoid triggers – keep a symptom diary to pinpoint allergens, fabrics, or environmental changes.
• Wear soft, breathable clothing – cotton or silk, avoid wool and synthetic fibers that irritate.
• Control indoor humidity – keep humidity between 40‑60 % to prevent drying.
• Use hypoallergenic detergents – free of fragrances and dyes.
• Manage stress – stress can exacerbate eczema; practices such as mindfulness, yoga, or counseling are beneficial.
• Limit hot showers – hot water strips natural oils; use lukewarm water instead.
• Stay up to date on vaccinations – infections can trigger severe eczema flares.
• Regular follow‑up with a dermatologist – especially for children with a strong family history of atopy.

Emergency Warning Signs

Key Take‑aways

Dimpled skin is a visual clue that eczema or another inflammatory dermatosis is active and the skin barrier is compromised. Early moisturization, avoidance of triggers, and appropriate use of topical therapies usually keep the condition under control. However, persistent itching, signs of infection, or systemic symptoms warrant prompt medical evaluation. With proper management and preventive measures, most individuals can achieve clear skin and a good quality of life.